Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 29;6(11):e967.
doi: 10.1038/tp.2016.239.

Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

Affiliations

Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

L M Rowland et al. Transl Psychiatry. .

Abstract

Various lines of evidence suggest that brain bioenergetics and mitochondrial function may be altered in schizophrenia. On the basis of prior phosphorus-31 (31P)-magnetic resonance spectroscopy (MRS), post-mortem and preclinical studies, this study was designed to test the hypothesis that abnormal glycolysis leads to elevated lactate concentrations in subjects with schizophrenia. The high sensitivity of 7 Tesla proton (1H)-MRS was used to measure brain lactate levels in vivo. Twenty-nine controls and 27 participants with schizophrenia completed the study. MRS scanning was conducted on a Philips 'Achieva' 7T scanner, and spectra were acquired from a voxel in the anterior cingulate cortex. Patients were assessed for psychiatric symptom severity, and all participants completed the MATRICS Consensus Cognitive Battery (MCCB) and University of California, San Diego Performance-Based Skills Assessment (UPSA). The relationship between lactate, psychiatric symptom severity, MCCB and UPSA was examined. Lactate was significantly higher in patients compared with controls (P=0.013). Higher lactate was associated with lower MCCB (r=-0.36, P=0.01) and UPSA total scores (r=-0.43, P=0.001). We believe this is the first study to report elevated in vivo cerebral lactate levels in schizophrenia. Elevated lactate levels in schizophrenia may reflect increased anaerobic glycolysis possibly because of mitochondrial dysfunction. This study also suggests that altered cerebral bioenergetics contribute to cognitive and functional impairments in schizophrenia.

PubMed Disclaimer

Conflict of interest statement

LEH reported receiving or planning to receive research funding or consulting fees from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho Pharmaceutical, Heptares and Pfizer. The remaining authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Representative anterior cingulate voxel location illustrated in red. (b) Representative in vivo spectrum (black line), LCModel fit (red line), residual (black line at top) and individual metabolite fits below. Asp, aspartate; Cr, creatine; GABA, gamma-aminobutyric acid; Gln, glutamine; Glu, glutamate; Lac, lactate; MM, macromolecules; ml, myo-inositol; NAA, n-acetylaspartate; NAAG, n-acetylaspartylglutamate; PCr, phosphocreatine; Ser, serine; Tau, taurine; tCho, phosphocholine+glycerophosphocholine.
Figure 2
Figure 2
The mean (s.d. bars) lactate levels by diagnostic group. Lactate levels were significantly higher in schizophrenia compared with the control group (P<0.05).
Figure 3
Figure 3
(a) A correlation scatter plot illustrating the negative relationship between lactate levels and general cognition function assess with the MCCB (total score). Schizophrenia group, gray circles, dashed trend line with r=−0.18, P>0.05. Control group, white squares, solid trend line with r=−0.10, P>0.05. Both groups combined, r=−0.36, P=0.01. (b) A correlation scatter plot illustrating the negative relationship between lactate levels and functional capacity assessed with the UPSA (total score). Schizophrenia group, gray circles, dashed trend line with r=−0.40, P<0.05. Control group, white squares, solid trend line with r=−0.008, P>0.05. Both groups combined, r=−0.43, P=0.001. MCCB, MATRICS Consensus Cognitive Battery; UPSA, University of California, San Diego Performance-Based Skills Assessment.

References

    1. Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al. Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 2012; 13: 293–307. - PubMed
    1. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004; 9: 684–697, 643. - PubMed
    1. Halim ND, Lipska BK, Hyde TM, Deep-Soboslay A, Saylor EM, Herman MM et al. Increased lactate levels and reduced pH in postmortem brains of schizophrenics: medication confounds. J Neurosci Methods 2008; 169: 208–213. - PMC - PubMed
    1. Roberts RC, Barksdale KA, Roche JK, Lahti AC. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophr Res 2015; 168: 543–553. - PMC - PubMed
    1. das Neves Duarte JM, Kulak A, Gholam-Razaee MM, Cuenod M, Gruetter R, Do KQ. N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development. Biol Psychiatry 2012; 71: 1006–1014. - PubMed

Publication types